MediWound Competitors and Similar CompaniesClear all

Immatics's competitors and similar companies include Alexion Pharmaceuticals and Ansun BioPharma.

	Immatics Immatics is a biotechnology company that is primarily engaged in the research and development of T cell redirecting immunotherapies for the treatment of cancer.	Alexion Pharmaceuticals Alexion (also known as Alexion, AstraZeneca Rare Disease) is a biopharmaceutical company engaged in therapies for rare diseases.	Ansun BioPharma Ansun BioPharma is a biopharmaceutical company focused on the development of host-directed anti-viral therapies for respiratory viruses.
Founding Date	Founding Date N/A	Founding Date 1992	Founding Date 2003
Type	Type Public	Type Public	Type Private
Tags	Tags Healthcare biotech pharma therapy	Tags Healthcare biotech pharma therapy	Tags Healthcare biotech pharma therapy
Locations	Locations Tübingen, DE HQ Frankfurt Am Main, DE München, DE Houston, US	Locations Boston, US HQ Frenchs Forest, AU Wien, AT Elsene, BE São Paulo, BR Vaughan, CA Shanghai, CN see more	Locations San Diego, US HQ
Employees	Employees 29723% increase	Employees 10,6006% increase	Employees 22
Valuation ($)	Valuation ($) 1.1 b	Valuation ($) 40.3 b	Valuation ($) N/A
Financial
Revenue (est.)	Revenue (est.) €48.3m (FY, 2025)	Revenue (est.) $6.1b (FY, 2020)	Revenue (est.) N/A
Cost of goods	Cost of goods N/A	Cost of goods $553.5m (FY, 2020)	Cost of goods N/A
Gross profit	Gross profit €53m (FY, 2025)	Gross profit $5.5b (FY, 2020)	Gross profit N/A
Net income	Net income (€196.4m) (FY, 2025)	Net income $603.4m (FY, 2020)	Net income N/A
Funding
Total funding raised	Total funding raised $ 267.3m	Total funding raised N/A	Total funding raised $ 183.9m